# Sycamore Biopharma, Inc.: Form D filings

Sycamore Biopharma, Inc., a biotechnology company in West Columbia, SC, filed 2 Form D notices with the SEC between 2019 and 2021. The latest, on March 5, 2021, reports an offering of $175,000 with nothing sold yet.

Find out what Sycamore Biopharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Sycamore%20Biopharma%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Sycamore%20Biopharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsycamore-biopharma-inc-1797706)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Sycamore%20Biopharma%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Sycamore%20Biopharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsycamore-biopharma-inc-1797706)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in South Carolina](https://specstream.ai/data/form-d/state/south-carolina): 341 rows, by operating companies, filed since November 1, 2024, $17.05, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/south-carolina
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 167 Lott Ct., West Columbia, SC, 29169
- Phone: (803) 206-1290
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: South Carolina
- Year incorporated: 2018
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1797706

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 5, 2021 | New notice | $175,000 | $0 | $175,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1797706/000179770621000001/0001797706-21-000001-index.htm) |
| Dec 20, 2019 | New notice | $500,000 | $500,000 | $0 | 5 | Dec 12, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1797706/000179770619000001/0001797706-19-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Chris Sadek | Director |  |
| William T. Lamar | Executive Officer, Director |  |
| Mark T. Hamann | Executive Officer, Director |  |
| R. Tyler Stone III | Executive Officer, Director |  |
| H. Lee T. Mashburn, Jr. | Executive Officer, Director |  |

[Every Form D from the week of Mar 1, 2021](https://specstream.ai/data/form-d/week/2021-03-01) · [All recent filings in South Carolina](https://specstream.ai/data/form-d/state/south-carolina) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Sycamore Biopharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).
